Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 23 · below the Ichimoku cloud · RSI 40 · MACD below its signal
None of the 29 investors followed here reported a position in DOGP in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a DOGP trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | Tobias DavidOfficer, Director and Beneficial Owner | Sale at price 0.01 per share. | 319.2K | $2.75K |
| Sep 16, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.01 per share. | 125K | $1.07K |
| Sep 16, 2026 | Tobias DavidOfficer, Director and Beneficial Owner | Purchase at price 0.01 per share. | 125K | $1.00K |
| Sep 13, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.01 per share. | 480K | $6.24K |
| Jul 21, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.01 per share. | 347.5K | $2.66K |
| Jun 29, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.01 per share. | 350K | $2.77K |
| Apr 26, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.01 per share. | 599.8K | $7.50K |
| Apr 20, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.01 per share. | 200K | $2.70K |
| Apr 5, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.02 per share. | 100K | $1.50K |
| Feb 11, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.02 per share. | 435K | $7.98K |
| Feb 11, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.02 per share. | 435K | $7.96K |
| Feb 1, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.02 per share. | 266.3K | $5.06K |
| Jan 15, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.02 per share. | 430.6K | $8.34K |
| Jan 14, 2026 | Tobias DavidChief Executive Officer | Sale at price 0.02 per share. | 206.3K | $3.92K |
| Dec 28, 2025 | Tobias DavidChief Executive Officer | Sale at price 0.02 per share. | 262.9K | $3.97K |
| Nov 16, 2025 | Tobias DavidChief Executive Officer | Sale at price 0.03 per share. | 3.20M | $97.51K |
| Sep 7, 2025 | Tobias DavidChief Executive Officer | Sale at price 0.03 per share. | 250.2K | $7.50K |
| Sep 4, 2025 | Tobias DavidChief Executive Officer | Sale at price 0.03 per share. | 75K | $2.09K |
| Jul 7, 2025 | Tobias DavidChief Executive Officer | Sale at price 0.03 per share. | 437.6K | $12.96K |
| Jul 6, 2025 | Tobias DavidChief Executive Officer | Sale at price 0.03 per share. | 200K | $5.46K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.0 | -25.6 | 0.0 | -8.3 | 0.8 | -37.3 | -14.3 | -8.3 | 9.1 | -11.1 | −62.6% | ||
| 2025 | -33.6 | -23.9 | -7.3 | -24.3 | -5.2 | -0.3 | 30.1 | -26.1 | 3.2 | -9.0 | -24.2 | -14.5 | −80.3% |
| 2024 | 143.3 | -45.7 | 51.3 | 33.3 | -8.3 | -36.4 | -42.9 | -27.5 | -12.1 | 111.8 | 437.0 | 50.0 | +866.7% |
| 2023 | 38.9 | 50.2 | -45.4 | 4.9 | -18.4 | -39.6 | 1.4 | -8.4 | -54.8 | -57.3 | 18.4 | 100.0 | −75.0% |
| 2022 | 18.8 | -5.7 | 10.8 | -26.0 | -19.0 | -20.7 | 5.8 | -31.6 | -21.1 | -8.3 | -0.2 | -34.4 | −79.8% |
| 2021 | 51.0 | 15.9 | -14.3 | -19.4 | -10.9 | -1.3 | -21.5 | -2.6 | -11.1 | -7.2 | -22.3 | -28.8 | −62.9% |
| 2020 | 116.7 | -35.0 | -5.6 | -14.1 | 1.4 | 4.8 | -17.4 | -3.9 | -32.7 | 5.7 | 97.4 | -34.2 | −11.1% |
| 2019 | 33.0 | -13.2 | -17.1 | -18.0 | -9.8 | -30.1 | 37.8 | -30.1 | -27.7 | -28.7 | -14.8 | -5.4 | −80.2% |
| 2018 | -7.0 | -5.4 | -30.1 | 8.4 | -7.0 | -19.9 | -16.9 | 37.7 | 23.8 | -2.9 | -19.1 | -23.1 | −57.5% |
| 2017 | 37.0 | -18.5 | -1.8 | -13.7 | -0.4 | -14.3 | -3.0 | -35.7 | 9.6 | -7.4 | 43.1 | 62.5 | +18.9% |
| 2016 | -11.0 | -36.4 | 474.5 | 0.2 | -19.3 | -7.6 | 10.3 | 21.1 | 30.0 | 123.4 | -24.4 | 8.4 | +671.4% |
| 2015 | 18.8 | -26.8 | -40.0 | 1.7 | -29.5 | -7.4 | -19.5 | 11.7 | 2.3 | -48.2 | -25.4 | -17.6 | −89.9% |
| 2014 | 1193.3 | 13.4 | -28.6 | -17.2 | -15.4 | -27.3 | 168.8 | -16.7 | -10.4 | 4.1 | -5.4 | -12.7 | +820.0% |
| 2013 | 0.0 | 0.0 | 0.0 | -39.5 | 0.0 | 0.0 | 0.0 | 39.2 | 0.0 | 0.0 | 0.0 | 5.6 | −11.0% |
| 2012 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 65.3 | 0.0 | +65.3% |
No analyst coverage for this instrument.
Dogecoin Cash, Inc., through its subsidiaries, provides online telehealth referral services through the PrestoDoctor platform in the United States. The company offers the technology platform and administrative support that facilitate telemedicine consultations between patients and licensed physicians. In addition, it maintains cannabis-related intellectual property. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.
No recent headlines.